Skip to content
News

Oncology company Thyme Care raises $125M, backed by Morgan Health, Humana and CVS Health Ventures

September 2, 2026

September 2, 2026

Thyme Care landed a series E financing round of more than $125 million backed by strategic payers and providers as it aims to expand beyond cancer care navigation.

This article was originally published on Fierce Healthcare.